SHANGHAI and CAMBRIDGE, Mass, Nov. 14, 2026 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today announced that five of its commercial medicines in China have been included in the country's 2026 National Reimbursement Drug List (NRDL). The update includes two first-time listings,...
- Showing World NX Group's "will toward the future" Manifested in Its Support for Evolution in Semiconductor and Automotive Industries - TOKYO, Jan....
SINGAPORE, Jan. 20, 2026 /PRNewswire/ -- This Ramadan, Four Points by Sheraton Singapore, Riverview invites guests to gather and break fast over a comforting spread...